Veterinary Supplements Market (Supplement Type: Antioxidants, Vitamins, Proteins/Amino acids, Enzymes, Probiotics, Essential Fatty Acids, and Others; Animal Type: Companion Animals and Livestock) - Global Industry Analysis, Size, Share, Growth, Trends, an

Veterinary Supplements Market (Supplement Type: Antioxidants, Vitamins, Proteins/Amino acids, Enzymes, Probiotics, Essential Fatty Acids, and Others; Animal Type: Companion Animals and Livestock) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031


Veterinary Supplements Market – Scope of Report

TMR’s report on the global veterinary supplements market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global veterinary supplements market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global veterinary supplements market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the veterinary supplements market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global veterinary supplements market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global veterinary supplements market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global veterinary supplements market.

The report delves into the competitive landscape of the global veterinary supplements market. Key players operating in the global veterinary supplements market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global veterinary supplements market profiled in this report.

Key Questions Answered in Global Veterinary Supplements Market Report
  • What is the sales/revenue generated by veterinary supplements across all regions during the forecast period?
  • What are the opportunities in the global veterinary supplements market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Veterinary Supplements Market – Research Objectives and Research Approach

The comprehensive report on the global veterinary supplements market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global veterinary supplements market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global veterinary supplements market.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Veterinary Supplements Market
4. Market Overview
4.1. Introduction
4.1.1. Supplement Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Veterinary Supplements Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Insights on The impact of e-commerce on the pet sales landscape
5.2. U.S. pet ownership statistics
5.3. Regulatory Scenario by Region/Globally
5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Veterinary Supplements Market Analysis and Forecast, by Supplement Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Supplement Type, 2017-2031
6.3.1. Antioxidants
6.3.2. Vitamins
6.3.3. Proteins/Amino acids
6.3.4. Enzymes
6.3.5. Probiotics
6.3.6. Essential Fatty Acids
6.3.7. Others
6.4. Market Attractiveness Analysis, by Supplement Type
7. Global Veterinary Supplements Market Analysis and Forecast, by Animal Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Animal Type, 2017-2031
7.3.1. Companion Animals
7.3.1.1. Dog
7.3.1.2. Cat
7.3.2. Livestock
7.3.2.1. Cattle
7.3.2.2. Horse
7.3.2.3. Sheep
7.3.3. Others
7.4. Market Attractiveness Analysis, by Animal Type
8. Global Veterinary Supplements Market Analysis and Forecast, by Application/Benefit Area
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application/Benefit Area, 2017-2031
8.3.1. Joint Health Support
8.3.2. Calming/Stress/Anxiety
8.3.3. Digestive Health
8.3.4. Energy & Electrolytes
8.3.5. Immunity Support
8.3.6. Skin & Coat Health
8.3.7. Others
8.4. Market Attractiveness Analysis, by Application/Benefit Area
9. Global Veterinary Supplements Market Analysis and Forecast, by Dosage Form
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Dosage Form, 2017-2031
9.3.1. Pills & Tablets
9.3.2. Chewables
9.3.3. Powders
9.3.4. Others
9.4. Market Attractiveness Analysis, by Dosage Form
10. Global Veterinary Supplements Market Analysis and Forecast, by Distribution Channel
10.1. Introduction & Definition
10.2. Key Findings/Developments
10.3. Market Value Forecast, by Distribution Channel, 2017-2031
10.3.1. Small Animal Veterinary
10.3.2. Large Animal Veterinary
10.3.3. Mixed Animal Veterinary
10.3.4. Retail Stores
10.3.5. Drug Stores
10.3.6. Online Sales
10.4. Market Attractiveness Analysis, by Distribution Channel
11. Global Veterinary Supplements Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region, 2017-2031
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness Analysis, by Region
12. North America Veterinary Supplements Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Supplement Type, 2017-2031
12.2.1. Antioxidants
12.2.2. Vitamins
12.2.3. Proteins/Amino acids
12.2.4. Enzymes
12.2.5. Probiotics
12.2.6. Essential Fatty Acids
12.2.7. Others
12.3. Market Value Forecast, by Animal Type, 2017-2031
12.3.1. Companion Animals
12.3.1.1. Dog
12.3.1.2. Cat
12.3.2. Livestock
12.3.2.1. Cattle
12.3.2.2. Horse
12.3.2.3. Sheep
12.3.3. Others
12.4. Market Value Forecast, by Application/Benefit Area, 2017-2031
12.4.1. Joint Health Support
12.4.2. Calming/Stress/Anxiety
12.4.3. Digestive Health
12.4.4. Energy & Electrolytes
12.4.5. Immunity Support
12.4.6. Skin & Coat Health
12.4.7. Others
12.5. Market Value Forecast, by Dosage Form, 2017-2031
12.5.1. Pills & Tablets
12.5.2. Chewables
12.5.3. Powders
12.5.4. Others
12.6. Market Value Forecast, by Distribution Channel, 2017-2031
12.6.1. Small Animal Veterinary
12.6.2. Large Animal Veterinary
12.6.3. Mixed Animal Veterinary
12.6.4. Retail Stores
12.6.5. Drug Stores
12.6.6. Online Sales
12.7. Market Value Forecast, by Country, 2017-2031
12.7.1. U.S.
12.7.2. Canada
12.8. Market Attractiveness Analysis
12.8.1. By Supplement Type
12.8.2. By Animal Type
12.8.3. By Application/Benefit Area
12.8.4. By Dosage Form
12.8.5. By Distribution Channel
12.8.6. By Country
13. Europe Veterinary Supplements Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Supplement Type, 2017-2031
13.2.1. Antioxidants
13.2.2. Vitamins
13.2.3. Proteins/Amino acids
13.2.4. Enzymes
13.2.5. Probiotics
13.2.6. Essential Fatty Acids
13.2.7. Others
13.3. Market Value Forecast, by Animal Type, 2017-2031
13.3.1. Companion Animals
13.3.1.1. Dog
13.3.1.2. Cat
13.3.2. Livestock
13.3.2.1. Cattle
13.3.2.2. Horse
13.3.2.3. Sheep
13.3.3. Others
13.4. Market Value Forecast, by Application/Benefit Area, 2017-2031
13.4.1. Joint Health Support
13.4.2. Calming/Stress/Anxiety
13.4.3. Digestive Health
13.4.4. Energy & Electrolytes
13.4.5. Immunity Support
13.4.6. Skin & Coat Health
13.4.7. Others
13.5. Market Value Forecast, by Dosage Form, 2017-2031
13.5.1. Pills & Tablets
13.5.2. Chewables
13.5.3. Powders
13.5.4. Others
13.6. Market Value Forecast, by Distribution Channel, 2017-2031
13.6.1. Small Animal Veterinary
13.6.2. Large Animal Veterinary
13.6.3. Mixed Animal Veterinary
13.6.4. Retail Stores
13.6.5. Drug Stores
13.6.6. Online Sales
13.7. Market Value Forecast, by Country/Sub-region, 2017-2031
13.7.1. Germany
13.7.2. U.K.
13.7.3. France
13.7.4. Italy
13.7.5. Spain
13.7.6. Rest of Europe
13.8. Market Attractiveness Analysis
13.8.1. By Supplement Type
13.8.2. By Animal Type
13.8.3. By Application/Benefit Area
13.8.4. By Dosage Form
13.8.5. By Distribution Channel
13.8.6. By Country/Sub-region
14. Asia Pacific Veterinary Supplements Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Supplement Type, 2017-2031
14.2.1. Antioxidants
14.2.2. Vitamins
14.2.3. Proteins/Amino acids
14.2.4. Enzymes
14.2.5. Probiotics
14.2.6. Essential Fatty Acids
14.2.7. Others
14.3. Market Value Forecast, by Animal Type, 2017-2031
14.3.1. Companion Animals
14.3.1.1. Dog
14.3.1.2. Cat
14.3.2. Livestock
14.3.2.1. Cattle
14.3.2.2. Horse
14.3.2.3. Sheep
14.3.3. Others
14.4. Market Value Forecast, by Application/Benefit Area, 2017-2031
14.4.1. Joint Health Support
14.4.2. Calming/Stress/Anxiety
14.4.3. Digestive Health
14.4.4. Energy & Electrolytes
14.4.5. Immunity Support
14.4.6. Skin & Coat Health
14.4.7. Others
14.5. Market Value Forecast, by Dosage Form, 2017-2031
14.5.1. Pills & Tablets
14.5.2. Chewables
14.5.3. Powders
14.5.4. Others
14.6. Market Value Forecast, by Distribution Channel, 2017-2031
14.6.1. Small Animal Veterinary
14.6.2. Large Animal Veterinary
14.6.3. Mixed Animal Veterinary
14.6.4. Retail Stores
14.6.5. Drug Stores
14.6.6. Online Sales
14.7. Market Value Forecast, by Country/Sub-region, 2017-2031
14.7.1. China
14.7.2. Japan
14.7.3. India
14.7.4. Australia & New Zealand
14.7.5. Rest of Asia Pacific
14.8. Market Attractiveness Analysis
14.8.1. By Supplement Type
14.8.2. By Animal Type
14.8.3. By Application/Benefit Area
14.8.4. By Dosage Form
14.8.5. By Distribution Channel
14.8.6. By Country/Sub-region
15. Latin America Veterinary Supplements Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Supplement Type, 2017-2031
15.2.1. Antioxidants
15.2.2. Vitamins
15.2.3. Proteins/Amino acids
15.2.4. Enzymes
15.2.5. Probiotics
15.2.6. Essential Fatty Acids
15.2.7. Others
15.3. Market Value Forecast, by Animal Type, 2017-2031
15.3.1. Companion Animals
15.3.1.1. Dog
15.3.1.2. Cat
15.3.2. Livestock
15.3.2.1. Cattle
15.3.2.2. Horse
15.3.2.3. Sheep
15.3.3. Others
15.4. Market Value Forecast, by Application/Benefit Area, 2017-2031
15.4.1. Joint Health Support
15.4.2. Calming/Stress/Anxiety
15.4.3. Digestive Health
15.4.4. Energy & Electrolytes
15.4.5. Immunity Support
15.4.6. Skin & Coat Health
15.4.7. Others
15.5. Market Value Forecast, by Dosage Form, 2017-2031
15.5.1. Pills & Tablets
15.5.2. Chewables
15.5.3. Powders
15.5.4. Others
15.6. Market Value Forecast, by Distribution Channel, 2017-2031
15.6.1. Small Animal Veterinary
15.6.2. Large Animal Veterinary
15.6.3. Mixed Animal Veterinary
15.6.4. Retail Stores
15.6.5. Drug Stores
15.6.6. Online Sales
15.7. Market Value Forecast, by Country/Sub-region, 2017-2031
15.7.1. Brazil
15.7.2. Mexico
15.7.3. Rest of Latin America
15.8. Market Attractiveness Analysis
15.8.1. By Supplement Type
15.8.2. By Animal Type
15.8.3. By Application/Benefit Area
15.8.4. By Dosage Form
15.8.5. By Distribution Channel
15.8.6. By Country/Sub-region
16. Middle East & Africa Veterinary Supplements Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Supplement Type, 2017-2031
16.2.1. Antioxidants
16.2.2. Vitamins
16.2.3. Proteins/Amino acids
16.2.4. Enzymes
16.2.5. Probiotics
16.2.6. Essential Fatty Acids
16.2.7. Others
16.3. Market Value Forecast, by Animal Type, 2017-2031
16.3.1. Companion Animals
16.3.1.1. Dog
16.3.1.2. Cat
16.3.2. Livestock
16.3.2.1. Cattle
16.3.2.2. Horse
16.3.2.3. Sheep
16.3.3. Others
16.4. Market Value Forecast, by Application/Benefit Area, 2017-2031
16.4.1. Joint Health Support
16.4.2. Calming/Stress/Anxiety
16.4.3. Digestive Health
16.4.4. Energy & Electrolytes
16.4.5. Immunity Support
16.4.6. Skin & Coat Health
16.4.7. Others
16.5. Market Value Forecast, by Dosage Form, 2017-2031
16.5.1. Pills & Tablets
16.5.2. Chewables
16.5.3. Powders
16.5.4. Others
16.6. Market Value Forecast, by Distribution Channel, 2017-2031
16.6.1. Small Animal Veterinary
16.6.2. Large Animal Veterinary
16.6.3. Mixed Animal Veterinary
16.6.4. Retail Stores
16.6.5. Drug Stores
16.6.6. Online Sales
16.7. Market Value Forecast, by Country/Sub-region, 2017-2031
16.7.1. GCC Countries
16.7.2. South Africa
16.7.3. Rest of Middle East & Africa
16.8. Market Attractiveness Analysis
16.8.1. By Supplement Type
16.8.2. By Animal Type
16.8.3. By Application/Benefit Area
16.8.4. By Dosage Form
16.8.5. By Distribution Channel
16.8.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player - Competition Matrix (by tier and size of companies)
17.2. Market Share Analysis, by Company, 2022
17.3. Company Profiles
17.3.1. Zoetis
17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.1.2. Product Portfolio
17.3.1.3. Financial Overview
17.3.1.4. SWOT Analysis
17.3.1.5. Strategic Overview
17.3.2. Ceva Sante Animale
17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.2.2. Product Portfolio
17.3.2.3. Financial Overview
17.3.2.4. SWOT Analysis
17.3.2.5. Strategic Overview
17.3.3. Elanco Animal Health
17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.3.2. Product Portfolio
17.3.3.3. Financial Overview
17.3.3.4. SWOT Analysis
17.3.3.5. Strategic Overview
17.3.4. Vetoquinol S.A.
17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.4.2. Product Portfolio
17.3.4.3. Financial Overview
17.3.4.4. SWOT Analysis
17.3.4.5. Strategic Overview
17.3.5. Dechra Pharmaceuticals plc
17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.5.2. Product Portfolio
17.3.5.3. Financial Overview
17.3.5.4. SWOT Analysis
17.3.5.5. Strategic Overview
17.3.6. Merck Animal Health
17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.6.2. Product Portfolio
17.3.6.3. Financial Overview
17.3.6.4. SWOT Analysis
17.3.6.5. Strategic Overview
17.3.7. Virbac S.A.
17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.7.2. Product Portfolio
17.3.7.3. Financial Overview
17.3.7.4. SWOT Analysis
17.3.7.5. Strategic Overview
17.3.8. Boehringer Ingelheim
17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.8.2. Product Portfolio
17.3.8.3. Financial Overview
17.3.8.4. SWOT Analysis
17.3.8.5. Strategic Overview
17.3.9. Norbrook Laboratories Limited
17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.9.2. Product Portfolio
17.3.9.3. Financial Overview
17.3.9.4. SWOT Analysis
17.3.9.5. Strategic Overview
17.3.10. Hester Biosciences Limited
17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.10.2. Product Portfolio
17.3.10.3. Financial Overview
17.3.10.4. SWOT Analysis
17.3.10.5. Strategic Overview
17.3.11. Merial Animal Health Limited
17.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.11.2. Product Portfolio
17.3.11.3. Financial Overview
17.3.11.4. SWOT Analysis
17.3.11.5. Strategic Overview
17.3.12. Novartis Animal Health, Inc.
17.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.12.2. Product Portfolio
17.3.12.3. Financial Overview
17.3.12.4. SWOT Analysis
17.3.12.5. Strategic Overview
17.3.13. Nutreco N.V.
17.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.13.2. Product Portfolio
17.3.13.3. Financial Overview
17.3.13.4. SWOT Analysis
17.3.13.5. Strategic Overview
17.3.14. Ouro Fino Saúde Animal
17.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.14.2. Product Portfolio
17.3.14.3. Financial Overview
17.3.14.4. SWOT Analysis
17.3.14.5. Strategic Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings